1 episode

Rheumatoid arthritis (RA) is a chronic autoimmune inflammatory disease affecting over 1.3 million Americans and as much as 1% of the worldwide population. The condition can be difficult to diagnose in its early stages because of non-specific early signs and symptoms that mimic many other diseases, and there is no singular confirmatory blood test or physical finding. But the evidence is clear: early diagnosis and treatment lead to improved outcomes for RA patients.
Rheumatoid Arthritis: Addressing Unmet Needs explores the many avenues of patient care for rheumatoid arthritis. From optimizing dialogue techniques with patients to updating the latest research horizons to addressing unique clinical scenarios such as RA during pregnancy, this series provides critical strategies and tools for RA management.
This non-certified educational series is sponsored by Lilly. Content for this series is produced and controlled by ReachMD. This series is intended for healthcare professionals only.
 Sponsored by

Rheumatoid Arthritis: Addressing Unmet Needs ReachMD

    • Science

Rheumatoid arthritis (RA) is a chronic autoimmune inflammatory disease affecting over 1.3 million Americans and as much as 1% of the worldwide population. The condition can be difficult to diagnose in its early stages because of non-specific early signs and symptoms that mimic many other diseases, and there is no singular confirmatory blood test or physical finding. But the evidence is clear: early diagnosis and treatment lead to improved outcomes for RA patients.
Rheumatoid Arthritis: Addressing Unmet Needs explores the many avenues of patient care for rheumatoid arthritis. From optimizing dialogue techniques with patients to updating the latest research horizons to addressing unique clinical scenarios such as RA during pregnancy, this series provides critical strategies and tools for RA management.
This non-certified educational series is sponsored by Lilly. Content for this series is produced and controlled by ReachMD. This series is intended for healthcare professionals only.
 Sponsored by

    Connecting Science to Psoriatic Arthritis Patient Care

    Connecting Science to Psoriatic Arthritis Patient Care

    Host: Matt Birnholz, MD

    Guest: Philip Mease, MD

    Guest: Allan Gibofsky, MD, JD, MACR, FACP, FCLM


    Science is moving forward in understanding the key inflammatory pathways involved in psoriasis and psoriatic arthritis, which has led to the development of targeted, effective therapies for patients with these diseases. But with these advances, it’s becoming more and more important for clinicians to understand how to choose treatment options appropriately and how to discuss them with patients.
    To explore the use of available treatments for psoriatic arthritis, Dr. Matt Birnholz sits down with Dr. Philip Mease and Dr. Allan Gibofsky.

Top Podcasts In Science

Listeners Also Subscribed To